BioSpace News Archive

Business

Evoke Pharma Reports Fourth Quarter and Full Year 2021 Financial Results

Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases, announced its financial results for the fourth quarter and full year ended December 31, 2021, and recent corporate developments.

March 8, 2022
·
12 min read
Genetown

Paratek Pharmaceuticals Announces the Publication of Data from an Investigator-Initiated Study of NUZYRA® (omadacycline) in a Hollow Fiber System Model Against Pulmonary Mycobacterium avium complex

Paratek Pharmaceuticals, Inc. announced the publication of data from an investigator-initiated study evaluating the activity of NUZYRA® in a dynamic hollow fiber model of Mycobacterium avium complex pulmonary infection.

March 8, 2022
·
9 min read
Business

Anika Reports Fourth Quarter and Year-End 2021 Financial Results

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its fourth quarter and full year ended December 31, 2021.

March 8, 2022
·
18 min read
Biotech Beach

Viking Therapeutics to Present at Upcoming Investor Conferences in March 2022

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will present at two upcoming investor conferences.

March 8, 2022
·
2 min read
Genetown

LogicBio Therapeutics to Present at Barclays Global Healthcare Conference

LogicBio® Therapeutics, Inc., a clinical-stage genetic medicine company, announced that president and chief executive officer, Frederic Chereau, will participate in a fireside chat during the Barclays Global Healthcare Conference on March 15, 2022, at 3:20 p.m. ET.

March 8, 2022
·
1 min read
Business

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results

Accelerate Diagnostics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2021.

March 8, 2022
·
12 min read
Business

Cumberland Pharmaceuticals Reports 2021 Financial Results & Company Update

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company announced full year 2021 financial results and provided a company update.

March 8, 2022
·
25 min read
Pharm Country

AngioDynamics to Present at Three Investor Conferences in March 2022

AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the following three investor conferences in March.

March 8, 2022
·
1 min read
Lone Star Bio

Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting

Bio-Path Holdings, Inc. announced an upcoming poster presentation at the 2022 American Association for Cancer Research Annual Meeting, taking place in Atlanta, GA on April 8-13, 2022.

March 8, 2022
·
3 min read
Biotech Bay

Iovance Biotherapeutics to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced the acceptance of two abstracts for presentation at the upcoming American Association for Cancer Research (AACR) 2022 Annual Meeting.

March 8, 2022
·
5 min read